好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Teriflunomide Shows Consistent Clinical Efficacy on Severe Relapses across Two Phase 3 Trials in Patients with Relapsing forms of Multiple Sclerosis, TEMSO and TOWER
Multiple Sclerosis
(-)
212
Authors/Disclosures
Richard A. Macdonell, MD, FAAN (Austin Health)
PRESENTER
Dr. Macdonell has nothing to disclose.
No disclosure on file
Mathias Maurer, MD No disclosure on file
Deborah Dukovic No disclosure on file
Philippe Truffinet, MD (Sanofi) Dr. Truffinet has received personal compensation for serving as an employee of Sanofi.
No disclosure on file
Catherine Dive-Pouletty (Sanofi-Aventis R&D) No disclosure on file
No disclosure on file